| XRayX vs Jin | 19–31 | 38.00% |
| XRayX vs Bryan | 18–28 | 39.13% |
| XRayX vs King | 18–24 | 42.86% |
| XRayX vs Kazuya | 22–20 | 52.38% |
| XRayX vs Hwoarang | 21–15 | 58.33% |
| XRayX vs Law | 19–16 | 54.29% |
| XRayX vs Steve | 11–21 | 34.38% |
| XRayX vs Armor King | 19–12 | 61.29% |
| XRayX vs Paul | 10–16 | 38.46% |
| XRayX vs Lili | 11–14 | 44.00% |
| XRayX vs Dragunov | 9–14 | 39.13% |
| XRayX vs Jun | 8–15 | 34.78% |
| XRayX vs Reina | 13–8 | 61.90% |
| XRayX vs Lee | 6–13 | 31.58% |
| XRayX vs Asuka | 9–9 | 50.00% |
| XRayX vs Azucena | 9–9 | 50.00% |
| XRayX vs Feng | 7–10 | 41.18% |
| XRayX vs Yoshimitsu | 6–10 | 37.50% |
| XRayX vs Lars | 7–8 | 46.67% |
| XRayX vs Devil Jin | 4–10 | 28.57% |
| XRayX vs Lidia | 4–9 | 30.77% |
| XRayX vs Leroy | 8–4 | 66.67% |
| XRayX vs Nina | 5–6 | 45.45% |
| XRayX vs Raven | 6–5 | 54.55% |
| XRayX vs Heihachi | 8–3 | 72.73% |
| XRayX vs Xiaoyu | 6–4 | 60.00% |
| XRayX vs Alisa | 5–5 | 50.00% |
| XRayX vs Claudio | 3–6 | 33.33% |
| XRayX vs Victor | 6–3 | 66.67% |
| XRayX vs Eddy | 2–6 | 25.00% |
| XRayX vs Jack-8 | 4–3 | 57.14% |
| XRayX vs Anna | 1–6 | 14.29% |
| XRayX vs Zafina | 2–2 | 50.00% |
| XRayX vs Leo | 3–0 | 100.00% |
| XRayX vs Kuma | 1–2 | 33.33% |
| XRayX vs Fahkumram | 3–0 | 100.00% |
| XRayX vs Panda | 1–1 | 50.00% |
| XRayX vs Clive | 1–1 | 50.00% |
| XRayX vs Shaheen | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.